Sumitomo Pharma Co., Ltd. (DNPUF) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Drug Manufacturers - Specialty & Generic उद्योग. कंपनी का मुख्यालय है Osaka, Japan. वर्तमान CEO हैं Toru Kimura.
DNPUF के पास है IPO तिथि 2012-01-17, 4,980 पूर्णकालिक कर्मचारी, पर सूचीबद्ध Other OTC, बाजार पूंजीकरण $4.41B.
Sumitomo Pharma Co., Ltd. is a Japan-based pharmaceutical manufacturer and supplier operating globally across North America, China, and other international markets. The company develops and markets a diverse therapeutic portfolio including treatments for Parkinson's disease, depression, type 2 diabetes, cancer, infectious diseases, and cardiovascular conditions, alongside specialty pharmaceuticals for rare diseases such as Fabry disease. Beyond pharmaceuticals, Sumitomo Pharma produces food ingredients and additives, chemical materials for industrial and personal care applications, and veterinary medicines for both companion and livestock animals. Founded in 1897 and headquartered in Osaka, the company maintains strategic partnerships with leading research institutions including Kyoto University, RIKEN, and the Center for iPS Cell Research, as well as collaborations with biotech firms such as Roivant Sciences. As a subsidiary of Sumitomo Chemical Company, Limited, Sumitomo Pharma combines established pharmaceutical expertise with innovation in emerging therapeutic areas.
